Akèy › Kansè (tout kalite) › Utah
Etid klinik pou Kansè (tout kalite) nan Utah
39 etid pou Kansè (tout kalite) ap chèche patisipan nan sit nan Utah.
Vil nan Utah
Tèks ofisyèl etid la (Anglè)
A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
- START Mountain Region ( Site 1106), West Valley City
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07209111A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
- Intermountain - Primary Children's Hospital ( Site 4014), Salt Lake City
Ap rekriteFaz 1/2
1 Month – 17 Years · Tout sèks · Mizajou Sep 25, 2026 · NCT07630974SAFE.AI: Developing and Testing an AI-based Hybrid Chatbot for Financial Empowerment in Rural Cancer Care
- Huntsman Cancer Institute/ University of Utah, Salt Lake City
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07410689A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
- Utah Cancer Specialists Cancer Center - Medical Oncology, Salt Lake City
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT06901531TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- Cedar City Hospital, SW Cancer Clinic, Sandra Maxwell Cancer Center, Cedar City
- Intermountain Healthcare, Salt Lake City
- Dixie Regional Medical Center-River Road Campus, St. George
Ap rekriteFaz 2
Laj 12 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT02693535Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- University of Utah - Huntsman Cancer Institute, Salt Lake City
- Intermountain Healthcare - LDS Hospital, Salt Lake City
Ap rekriteFaz 2/3
Tout laj · Tout sèks · Mizajou Sep 18, 2026 · NCT03435796A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
- Intermountain - Primary Children's Hospital ( Site 3014), Salt Lake City
Ap rekriteFaz 1/2
1 Month – 17 Years · Tout sèks · Mizajou Sep 17, 2026 · NCT06941272RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Cedar Clinical Research Inc., Draper
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 15, 2026 · NCT07002034(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- Huntsman Cancer Institute - University of Utah Health, Salt Lake City
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT04996875A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
- Huntsman Cancer Institute /ID# 271618, Salt Lake City
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT06953960A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
- Huntsman Cancer Institute, Salt Lake City
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT06634589A Phase 1/1b Study of IAM1363 in HER2 Cancers
- START Mountain Region, West Valley City
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06253871A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
- Community Cancer Trials of Utah, Ogden
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT07169851Project: Every Child for Younger Patients With Cancer
- Primary Children's Hospital, Salt Lake City
Ap rekriteEtid obsèvasyon
Jiska laj 25 · Tout sèks · Mizajou Aug 25, 2026 · NCT02402244A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer
- START Mountain Region, West Valley City
Ap rekriteFaz 1/2
Laj 12 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT06678659Abatacept in Immune Checkpoint Inhibitor Myocarditis
- University of Utah, Salt Lake City
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT05335928Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies
- Site 02, West Valley City
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT07276373A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors
- START Mountain Region, West Valley City
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 10, 2026 · NCT06880549Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- University of Utah Sugarhouse Health Center, Salt Lake City
- Huntsman Cancer Institute/University of Utah, Salt Lake City
- South Jordan Health Center, South Jordan
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT06580314A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
- Huntsman Cancer Institute /ID# 272575, Salt Lake City
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jul 21, 2026 · NCT06892522A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
- Huntsman Cancer Institute, University of Utah, Salt Lake City
- START Mountain Region, LLC., West Valley City
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jul 15, 2026 · NCT06657144Sun Exposure and Activities After Skin Cancer: Optimization of mHealth Interventions
- Huntsman Cancer Institute at The University of Utah, Salt Lake City
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 10, 2026 · NCT07556380First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- START Mountain Region, West Valley City
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT05768139A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
- GSK Investigational Site, West Valley City
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jun 25, 2026 · NCT06431594Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
- VA Salt Lake City Health Care System, Salt Lake City, UT, Salt Lake City
Ap rekrite
Laj 18 a 75 · Tout sèks · Mizajou Jun 17, 2026 · NCT05486572Galleri® in the Medicare Population.
- HCA Healthcare St. Marks, Salt Lake City
Ap rekriteVolontè an sante akeyi
Laj 50 ak plis · Tout sèks · Mizajou May 22, 2026 · NCT05673018A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
- GSK Investigational Site, West Valley City
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou May 22, 2026 · NCT06551142Heuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults With Cancer
- University of Utah Huntsman Cancer Institute (HCI), Salt Lake City
- University of Utah Primary Children's Hospital, Salt Lake City
Ap rekrite
Laj 15 a 29 · Tout sèks · Mizajou May 22, 2026 · NCT05958316I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou May 6, 2026 · NCT01042379Safety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With Relapsed or Refractory Lymphomas and Solid Tumors
- START Mountain Region, West Valley City
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou May 4, 2026 · NCT06132503Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Apr 30, 2026 · NCT05297734Improving Health Insurance Literacy Among Young Adult Cancer Survivors
- Intermountain Health, Murray
- University of Utah, Salt Lake City
Ap rekrite
Laj 26 a 45 · Tout sèks · Mizajou Apr 28, 2026 · NCT05829070CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Apr 16, 2026 · NCT03328078Enhancing Motivation to Quit Smoking Via Self-Help Intervention Targeted to Cancer Type
- Huntsman Cancer Institute, Salt Lake City
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Nov 26, 2025 · NCT06484179Dose-escalation Study to Assess Safety and Pharmacokinetics of Nab-Sirolimus in Patients With Locally Advanced or Metastatic Solid Tumors and Moderate Liver Impairment
- START Mountain Region, West Valley City
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Nov 13, 2025 · NCT05661461Childhood Cancer Predisposition Study (CCPS)
- Primary Children's Hospital, Salt Lake City
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Oct 29, 2025 · NCT04511806SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Salt Lake City
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
- Utah Cancer Specialists, Salt Lake City
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou May 6, 2025 · NCT05234177Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
- Intermountain Medical Center, Murray
- Huntsman Cancer Institute (The University of Utah), Salt Lake City
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Nov 27, 2024 · NCT03860883Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.